Ursodeoxycholic Acid Ameliorates Fructose-Induced Metabolic Syndrome in Rats - Mahmoud, Amr A. A.; Elshazly, Shimaa M. (PloS one, 2014)
Keywords: Acid resistance; Acids; Advanced glycosylation end products; Animals; Antioxidants; Aorta; Biology and Life Sciences; Blood; Blood glucose; Blood Glucose - drug effects; Blood pressure; Blood Pressure - drug effects; Body weight; Body Weight - drug effects; Cardiovascular disease; Cardiovascular diseases; Cholesterol; Cholesterol - blood; Diabetes; Diabetes mellitus; Drinking water; Drug dosages; Dyslipidemia; Elasticity; Endothelium; Fenofibrate; Fenofibrate - pharmacology; Fructose; Fructose - adverse effects; Gastroenterology; Glucose; Glutathione; Glutathione - metabolism; Glycation End Products, Advanced - blood; Glycosylation; Health risks; Heart diseases; Hepatitis; Hypertension; Infiltration; Inflammation; Insulin; Insulin - blood; Insulin resistance; Insulin Resistance - physiology; Leukocytes; Liver; Liver diseases; Male; Malondialdehyde; Malondialdehyde - metabolism; Medicine and Health Sciences; Metabolic disorders; Metabolic syndrome; Metabolic Syndrome - blood; Metabolic Syndrome - drug therapy; Metabolic Syndrome - metabolism; Nitric Oxide Synthase Type II - metabolism; Nitric Oxide Synthase Type III - metabolism; Nitric-oxide synthase; Nutrition research; Ostomy; Oxidation resistance; Oxidative stress; Oxidative Stress - drug effects; Peroxisome proliferator-activated receptors; Pharmacology; Pharmacy; Rats; Rats, Wistar; Receptors; Rodents; Tissues; Triglycerides; Triglycerides - blood; Uric acid; Uric Acid - blood; Ursodeoxycholic Acid - pharmacology; Egypt